A comparative analysis of perioperative complications and biochemical recurrence between standard and extended pelvic lymph node dissection in prostate cancer patients undergoing radical prostatectomy: a systematic review and meta-analysis

被引:4
作者
Ding, Guixin [1 ]
Tang, Gonglin [1 ]
Wang, Tianqi [1 ]
Zou, Qingsong [1 ]
Cui, Yuanshan [1 ]
Wu, Jitao [1 ]
机构
[1] Qingdao Univ, Yantai Yuhuangding Hosp, Dept Urol, 20 East Yuhuangding Rd, Yantai 264000, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
complications; lymph node dissection; prostate cancer; radical prostatectomy; surgical procedures; LYMPHADENECTOMY;
D O I
10.1097/JS9.0000000000000997
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction:Pelvic lymph node dissection (PLND) is commonly performed during radical prostatectomy (RP) for prostate cancer staging. This study aimed to comprehensively analyze existing evidence compare perioperative complications associated with standard (sPLND) versus extended PLND templates (ePLND) in RP patients. Methods:A meta-analysis of prospective studies on PLND complications was conducted. Systematic searches were performed on Web of Science, Pubmed, Embase, and the Cochrane Library until May 2023. Risk ratios (RRs) were estimated using random-effects models in the meta-analysis. The statistical analysis of the data was carried out using Review Manager software. Results:Nine studies, including three randomized clinical trial and six prospective studies, with a total of 4962 patients were analyzed. The meta-analysis revealed that patients undergoing ePLND had a higher risk of partial perioperative complications, such as lymphedema (I 2=28%; RR 0.05; 95% CI: 0.01-0.27; P<0.001) and urinary retention (I 2=0%; RR 0.30; 95% CI: 0.09-0.94; P=0.04) compared to those undergoing sPLND. However, there were no significant difference was observed in pelvic hematoma (I 2=0%; RR 1.65; 95% CI: 0.44-6.17; P=0.46), thromboembolic (I 2=57%; RR 0.91; 95% CI: 0.35-2.38; P=0.85), ureteral injury (I 2=33%; RR 0.28; 95% CI: 0.05-1.52; P=0.14), intraoperative bowel injury (I 2=0%; RR 0.87; 95% CI: 0.14-5.27; P=0.88), and lymphocele (I 2=0%; RR 1.58; 95% CI: 0.54-4.60; P=0.40) between sPLND and ePLND. Additionally, no significant difference was observed in overall perioperative complications (I 2=85%; RR 0.68; 95% CI: 0.40-1.16; P=0.16). Furthermore, ePLND did not significantly reduce biochemical recurrence (I 2=68%; RR 0.59; 95% CI: 0.28-1.24; P=0.16) of prostate cancer. Conclusion:This analysis found no significant differences in overall perioperative complications or biochemical recurrence between sPLND and ePLND, but ePLND may offer enhanced diagnostic advantages by increasing the detection rate of lymph node metastasis.
引用
收藏
页码:1735 / 1743
页数:9
相关论文
共 34 条
[1]   Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection [J].
Altok, Muammer ;
Babaian, Kara ;
Achim, Mary F. ;
Achim, Grace C. ;
Troncoso, Patricia ;
Matin, Surena F. ;
Chapin, Brian F. ;
Davis, John W. .
BJU INTERNATIONAL, 2018, 122 (01) :66-75
[2]   Standard versus extended pelvic lymphadenectomy in the patients with clinically localized prostate cancer [J].
Bogdanovic, Jovo ;
Sekulic, Vuk ;
Trivunic-Dajko, Sandra ;
Herin, Ranko ;
Djozic, Senjin .
VOJNOSANITETSKI PREGLED, 2019, 76 (09) :929-934
[3]   A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer [J].
Briganti, Alberto ;
Chun, Felix K-H. ;
Salonia, Andrea ;
Zanni, Giuseppe ;
Gallina, Andrea ;
Deho, Federico ;
Suardi, Nazareno ;
Da Pozzo, Luigi Filippo ;
Valiquette, Luc ;
Rigatti, Patrizio ;
Montorsi, Francesco ;
Karakiewicz, PierreI .
EUROPEAN UROLOGY, 2007, 51 (01) :112-120
[4]   Pelvic Lymph Node Dissection in Prostate Cancer [J].
Briganti, Alberto ;
Blute, Michael L. ;
Eastham, James H. ;
Graefen, Markus ;
Heidenreich, Axel ;
Karnes, Jeffrey R. ;
Montorsi, Francesco ;
Studer, Urs E. .
EUROPEAN UROLOGY, 2009, 55 (06) :1251-1265
[5]   Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion &gt;5%: a propensity score matching analysis from SEER database [J].
Chen, Junru ;
Wang, Zhipeng ;
Zhao, Jinge ;
Zhu, Sha ;
Sun, Guangxi ;
Liu, Jiandong ;
Zhang, Haoran ;
Zhang, Xingming ;
Shen, Pengfei ;
Shi, Ming ;
Zeng, Hao .
SCIENTIFIC REPORTS, 2019, 9 (1)
[6]   Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions [J].
Cumpston, Miranda ;
Li, Tianjing ;
Page, Matthew J. ;
Chandler, Jacqueline ;
Welch, Vivian A. ;
Higgins, Julian P. T. ;
Thomas, James .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (10)
[7]  
Deng H., 2023, Int J Surg
[8]   Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer [J].
Eden, Christopher G. ;
Arora, Avanish ;
Rouse, Paul .
BJU INTERNATIONAL, 2010, 106 (04) :537-542
[9]   The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review [J].
Fossati, Nicola ;
Willemse, Peter-Paul M. ;
Van den Broeck, Thomas ;
van den Bergh, Roderick C. N. ;
Yuan, Cathy Yuhong ;
Briers, Erik ;
Bellmunt, Joaquim ;
Bolla, Michel ;
Cornford, Philip ;
De Santis, Maria ;
MacPepple, Ekelechi ;
Henry, Ann M. ;
Mason, Malcolm D. ;
Matveev, Vsevolod B. ;
van der Poel, Henk G. ;
van der Kwast, Theo H. ;
Rouviere, Olivier ;
Schoots, Ivo G. ;
Wiegel, Thomas ;
Lam, Thomas B. ;
Mottet, Nicolas ;
Joniau, Steven .
EUROPEAN UROLOGY, 2017, 72 (01) :84-109
[10]  
Gandaglia G, 2018, EUR UROL, V73, pE131, DOI [10.1016/j.eururo.2018.01.015, 10.1016/j.eururo.2018.02.024]